Skip to main content
OpenTrials

Clinical trial condition

Salivary Gland Diseases

Explore clinical trials studying Salivary Gland Diseases. Study availability and eligibility vary by location and protocol.

710 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Salivary Gland Diseases trial results

Active, Not Recruiting

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

NCT03942653

Conditions
Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
Locations
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Univeristy of Maryland Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

NCT05985915

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Advanced Medical Research La Palma, California, United States
  • Medvin Clinical Research Van Nuys, California, United States
  • Bay Area Arthritis And Osteoporosis Brandon, Florida, United States
View all 197 locations
View Trial Details
Active, Not Recruiting

A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma

NCT04325828

Conditions
Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +5 more
Locations
  • National Cancer Center Hospital Chūōku, Japan
  • National Hospital Organization Kyushu Medical Center Fukuoka, Japan
  • Kansai Medical University Hospital Hirakata, Japan
  • National Hospital Organization Shikoku Cancer Center Matsuyama, Japan
View Trial Details
Active, Not Recruiting

Nipocalimab in Moderate to Severe Sjogren's Disease

NCT06741969

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Advanced Clinical Research Center Chula Vista, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Arthritis & Osteoporosis Medical Center - La Palma La Palma, California, United States
  • NovaMed Research Monterey Park, California, United States
View all 254 locations
View Trial Details
Active, Not Recruiting

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

NCT02650401

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Brain Diseases, +59 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Egleston Children's Hospital at Emory University Atlanta Atlanta, Georgia, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

NCT05669664

Conditions
Head and Neck Neoplasms, Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, +9 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

NCT05349214

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Advanced Medical Research La Palma, California, United States
  • Bay Area Arthritis And Osteoporosis Brandon, Florida, United States
  • GNP Research Cooper City, Florida, United States
View all 146 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details

Related conditions